These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6143773)

  • 41. Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients.
    Thompson M; Comings DE; Feder L; George SR; O'Dowd BF
    Am J Med Genet; 1998 May; 81(3):241-4. PubMed ID: 9603612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Tourette syndrome.
    Millichap JG
    Dev Med Child Neurol; 1999 May; 41(5):356. PubMed ID: 10378765
    [No Abstract]   [Full Text] [Related]  

  • 43. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.
    Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurological features of Gilles de la Tourette's syndrome.
    Sweet RD; Solomon GE; Wayne H; Shapiro E; Shapiro AK
    J Neurol Neurosurg Psychiatry; 1973 Feb; 36(1):1-9. PubMed ID: 4511776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propranolol treatment of akathesia in Tourette's syndrome.
    Chandler JD
    J Am Acad Child Adolesc Psychiatry; 1990 May; 29(3):475-7. PubMed ID: 2347850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tourette's syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationship.
    Knell ER; Comings DE
    J Clin Psychiatry; 1993 Sep; 54(9):331-7. PubMed ID: 8407852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
    Bruggeman R; van der Linden C; Buitelaar JK; Gericke GS; Hawkridge SM; Temlett JA
    J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Wilens T; Steingard R; Geist D
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering.
    Pauls DL; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1044-50. PubMed ID: 8407750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 'Prevalence of Tourette syndrome in a mainstream school population'.
    Traverse L
    Dev Med Child Neurol; 1998 Dec; 40(12):847-8. PubMed ID: 9881684
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between maternal smoking and increased symptom severity in Tourette's syndrome.
    Mathews CA; Bimson B; Lowe TL; Herrera LD; Budman CL; Erenberg G; Naarden A; Bruun RD; Freimer NB; Reus VI
    Am J Psychiatry; 2006 Jun; 163(6):1066-73. PubMed ID: 16741208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The stimulants.
    Wilens TE; Biederman J
    Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder.
    Feigin A; Kurlan R; McDermott MP; Beach J; Dimitsopulos T; Brower CA; Chapieski L; Trinidad K; Como P; Jankovic J
    Neurology; 1996 Apr; 46(4):965-8. PubMed ID: 8780073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parotid gland salivary secretion in Tourette's syndrome and attention deficit disorder: a model system for the study of neurochemical regulation.
    Cohen DJ; Ort S; Caruso KA; Anderson GM; Hunt RD; Shaywitz BA; Kremenitzer M; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1987 Jan; 26(1):65-8. PubMed ID: 3034852
    [No Abstract]   [Full Text] [Related]  

  • 56. Tourette's syndrome.
    Martin A
    Child Today; 1977; 6(1):26-7. PubMed ID: 264437
    [No Abstract]   [Full Text] [Related]  

  • 57. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tourette's syndrome.
    Jankovic J
    N Engl J Med; 2001 Oct; 345(16):1184-92. PubMed ID: 11642235
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children.
    Fras I; Karlavage J
    Am J Psychiatry; 1977 Feb; 134(2):195-7. PubMed ID: 264771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gilles de la Tourette's disease and minimal brain dysfunction: amphetamine isomers reveal catecholamine correlates in an affected patient.
    Meyerhoff JL; Snyder SH
    Psychopharmacologia; 1973; 29(3):211-20. PubMed ID: 4512896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.